Therapeutic, Clinicopathological, and Molecular Correlates of PRKACA Expression in Gastrointestinal Cancers
Open Access
- 25 September 2024
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (10) , 1263
Abstract
Background/Objectives: PRKACA alterations have clear diagnostic and biological roles in the fibrolamellar variant of hepatocellular carcinoma and a potential predictive role in that cancer type. However, the roles of PRKACA have not been comprehensively examined in gastric and colorectal cancers (GC and CRC). This study, therefore, sought to investigate the roles of PRKACA expression in GC and CRC. Methods: The clinico-genomic data of 441 GC and 629 CRC cases were analyzed for therapeutic, clinicopathological, and biological correlates using appropriate bioinformatics and statistical tools. Furthermore, the deregulation of PRKACA expression in GC and CRC was investigated using correlative and regression analyses. Results: The results showed that PRKACA expression subsets were enriched for gene targets of chemotherapeutics, tyrosine kinase, and β-adrenergic inhibitors. Moreover, high PRKACA expression was associated with adverse clinicopathological and genomic features of GC and CRC. Gene Ontology Enrichment Analysis also showed that PRKACA-high subsets of the GI cancers were enriched for the biological and molecular functions that are associated with cell motility, invasion, and metastasis but not cell proliferation. Finally, multiple regression analyses identified multiple methylation loci, transcription factors, miRNA species, and PRKACA copy number changes that deregulated PRKACA expression in GC and CRC. Conclusions: This study has identified potential predictive and clinicopathological roles for PRKACA expression in GI cancers and has added to the growing body of knowledge on the deregulation of PRKACA in cancer.Keywords
Funding Information
- Prince Sattam bin Abdulaziz University (PSAU/2023/R/1445)
This publication has 52 references indexed in Scilit:
- Evaluation of Protein Kinase cAMP-Activated Catalytic Subunit Alpha as a Therapeutic Target for Fibrolamellar CarcinomaGastro Hep Advances, 2022
- The seen and the unseen: Molecular classification and image based-analysis of gastrointestinal cancersComputational and Structural Biotechnology Journal, 2022
- Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysisCell Reports, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Identification of a CIP4 PKA phosphorylation site involved in the regulation of cancer cell invasiveness and metastasisCancer Letters, 2019
- Comparative Molecular Analysis of Gastrointestinal AdenocarcinomasCancer Cell, 2018
- Methods for High-throughput Drug Combination Screening and Synergy Scoring2018
- Cyclic AMP‐dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be nextThe Journal of Pathology, 2018
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015